Related references
Note: Only part of the references are listed.KRAS analysis in colorectal carcinoma: Analytical aspects of Pyrosequencing and allele-specific PCR in clinical practice
Magnus Sundstrom et al.
BMC CANCER (2010)
Overexpression of p53 is correlated with poor outcome in premenopausal women with breast cancer treated with tamoxifen after chemotherapy
Hee Sung Kim et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
p53 overexpression in morphologically ambiguous endometrial carcinomas correlates with adverse clinical outcomes
Karuna Garg et al.
MODERN PATHOLOGY (2010)
Worldwide Variations in Colorectal Cancer
Melissa M. Center et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
The Difference in p53 Mutations between Cancers of the Upper and Lower Gastrointestinal Tract
Eiji Oki et al.
DIGESTION (2009)
Mutation pattern of K-ras gene in colorectal cancer patients of Kashmir: A report
MA Siddiqi et al.
INDIAN JOURNAL OF CANCER (2009)
Genetic pathways to colorectal cancer
Isabel A. Lea et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2009)
Two subtypes of mucinous adenocarcinoma of the colorectum: Clinicopathological and genetic features
Sarli Leopoldo et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Colorectal carcinoma prognosis can be predicted by alterations in gene p53 exons 5 and 8
M. Vidaurreta et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2008)
Genetic alterations of APC, K-ras, p53, MSI, and MAGE in Korean colorectal cancer patients
Chang-Ho Jeon et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2008)
p53 protein accumulation as a prognostic marker in sporadic colorectal cancer
Yuan-Tzu Lan et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2007)
Recurrent KRAS Codon 146 mutations in human colorectal cancer
Sarah Edkins et al.
CANCER BIOLOGY & THERAPY (2006)
p53 alterations and protein accumulation in benign breast tissue and breast cancer risk: A cohort study
Thomas E. Rohan et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Functional categories of TP53 mutation in colorectal cancer:: results of an International Collaborative Study
B Iacopetta et al.
ANNALS OF ONCOLOGY (2006)
Polymorphisms in the p53 pathway
EC Pietsch et al.
ONCOGENE (2006)
Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines
Y Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Implications of CEA and p53 overexpression in the poor prognosis of colorectal cancer
WA Nasif et al.
MEDICAL ONCOLOGY (2006)
The prognostic significance of K-ras, p53, and APC mutations in colorectal carcinoma
A Conlin et al.
GUT (2005)
Determination of TP53 mutation is more relevant than microsatellite instability status for the prediction of disease-free survival in adjuvant-treated stage III colon cancer patients
JL Westra et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Mutation analysis of p53, k-ras, and BRAF genes in colorectal cancer progression
D Calistri et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2005)
Prognostic and predictive factors in colorectal cancer: Kirsten Ras in CRC (RASCAL) and TP53CRC collaborative studies
Antonio Russo et al.
ANNALS OF ONCOLOGY (2005)
Transcription, apoptosis and p53: catch-22
M Schuler et al.
TRENDS IN GENETICS (2005)
Pretreatment p53 nuclear overexpression as a prognostic marker in superficial bladder cancer-treated with Bacillus Calmette-Guerin (BCG)
F Saint et al.
EUROPEAN UROLOGY (2004)
Co-mutation of p53, K-ras genes and accumulation of p53 protein and its correlation to clinicopathological features in rectal cancer
Zhi-Zhong Pan et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2004)
Influence of age on adenomatous polyposis coli and p53 mutation frequency in sporadic colorectal cancer - rarity of co-occurrence of mutations in APC, K-ras, and p53 genes
JM Chiang et al.
VIRCHOWS ARCHIV (2004)
p53 protein accumulation in colorectal cancer tissue has prognostic value only in left-sided colon tumours
P Paluszkiewicz et al.
CANCER DETECTION AND PREVENTION (2004)
Significance of TP53 mutations in human cancer:: a critical analysis of mutations at CpG dinucleotides
T Soussi et al.
HUMAN MUTATION (2003)
Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers
GP Pfeifer et al.
ONCOGENE (2002)
Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype
V Bazan et al.
ANNALS OF ONCOLOGY (2002)
Mutations in APC, Kirsten-ras, and p53 - alternative genetic pathways to colorectal cancer
G Smith et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Prognostic significance of P53 mutations in colon cancer at the population level
WS Samowitz et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
P53 immunohistochemical scoring: an independent prognostic marker for patients after hepatocellular carcinoma resection
LX Qin et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2002)
Kirsten ras mutations in patients with colorectal cancer:: the 'RASCAL II' study
HJN Andreyev et al.
BRITISH JOURNAL OF CANCER (2001)
Prognostic significance of TP53 gene mutation in 995 cases of colorectal carcinoma:: influence of tumour site, stage, adjuvant chemotherapy and type of mutation
R Soong et al.
EUROPEAN JOURNAL OF CANCER (2000)
P53 and K-ras gene mutations in carcinoma of the rectum among Finnish women
K Servomaa et al.
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY (2000)
Share Paper
